LONGDOM CONFERENCES
European Summit on Pharmacology and Toxicology
DATES: MAY 04-05, 2020
PLACE: Vienna, Austria
Longdom proffers
our immense pleasure and honor in extending you a warm invitation to attend
Pharmacology Congress 2020 on MAY 4-5, 2020 in Vienna, Austria. It is focusing
on ‘Emerging Trends in Pharmacology’ to enhance and explore knowledge among The medical community and to establish corporations and exchanging ideas. Providing
the right stage to present stimulating Keynote talks, plenary sessions,
Discussion Panels, B2B Meetings, Poster symposia, Video Presentations, and
Workshops.
Pharmacology
Congress 2020 anticipates over 200 participants around the globe with
path-breaking subjects, discussions, and presentations. This will be splendid
feasibility for the researchers, delegates and the students from Universities
and Institutes to interact with world-class Scientists, speakers, surgeons,
Medical Practitioners, and Industry Professionals.
Dr.
Ravi P. Sahu,
Ph.D., Assistant Professor,
Department of Pharmacology and Toxicology
Video
Presentation- Deciphering phospholipid-based signaling mechanisms for lung cancer intervention
Ravi P. Sahu has completed his Ph.D. from Sanjay Gandhi Post Graduate Institute of Medical Sciences and postdoctoral studies from the University of Pittsburgh Medical Center, Texas Tech University Health Science Center and Indiana University School of Medicine. He is currently an Assistant Professor at the Department of Pharmacology and Toxicology at Wright State University Boonshoft School of Medicine at Dayton, OH. He has published over 50 papers in reputed scientific journals and has been serving as an editorial board member and adhoc reviewer of several journals.
Dr Muhammad Waqas,
Ph.D.,
Director of Johar Institute
of Professional Studies
Oral Presentation Academic Speaker:
The manifestation of Predictive Variables and Their Relationship to Establish Anaemia In Traffic Wardens Of Lahore City
Muhammad Waqas has completed his Ph.D. from IMBB, University of Lahore, Pakistan. He is the director of the Johar Institute of Professional Studies, a premier Pharmacy Institute. He has published more than 15 papers in reputed journals and has been serving as an editorial board member of reputed Journals
Dr
Alberto Morisetti,
BSc,
ERT.
Senior Pharmatox Advisor
Oral Presentation Business speaker: Pitfalls in Nonclinical Safety Data Evaluation
Alberto Morisetti has graduated in 1980 in Biological Sciences in Milan, Italy and is European Registered Toxicologist. Up to 2009, he worked as Study Director, Study Monitor, Head of Test Facilities for PharmaTox research and development. He is author/co-author of more than 30 scientific publications in the field of regulatory toxicology and pharmacology, mainly related to contrast media, imaging by different techniques, and regulatory issues, anticancer drugs. From 2010 he started the activity of consultancy in R&D for different Italian and foreign pharma companies, working on regulatory as well as industrial toxicology. His activity consists of drawing the nonclinical development plan, CRO selection, study monitoring and reviewing study reports, CTD and participating in meetings with regulatory authorities for anticancer, antibiotic, corticosteroid, medical device projects. Recent activities include EU Commission participation as the nonclinical expert.
Dr
Alexei G. Basnakian,
MD, Ph.D., DSc
Director, DNA Damage and Toxicology Core CenterProfessor, Department of Pharmacology & Toxicology
The University of Arkansas for Medical Sciences
(Dr. Alexei Basnakian-OCM Keynote speaker):
Alexei Basnakian received his MD in Internal Medicine from Sechenov Moscow Medical Academy, and Ph.D. & DSc degrees from the Russian Academy of Medical Science, both in the field of DNA-degrading enzymes. He had postdoctoral training in molecular biology at the Harvard Medical School and in toxicology/cancer research at the National Center for Toxicological Research/US Food and Drug Administration. Dr. Basnakian is a tenured Professor at the Department of Pharmacology and Toxicology, and Director of the DNA Damage and Toxicology Core Center at the University of Arkansas for Medical Sciences in Little Rock, Arkansas, USA. He is an author of 89 peer-reviewed papers and 14 reviews or book chapters. Dr. Basnakian is an Editorial Board member of 4 biomedical journals, and a member of NIH, AHA & VA grant study sections. His research interests are in DNases/endonucleases and DNA damage associated with toxicity, anti-cancer therapy, tissue injury& cell death.
DR SIRANUSH ASHOT MKRTCHYAN
ENT DepartmentE- poster presentation: New Approaches to The Evaluation Of Herbal Drug Efficacy In Treatment Of Chronic 
Siranush A.Mkrtchyan is a Lecturer at the ENT Department of Yerevan State Medical University, Armenia. Dr. Mkrtchyan works also in one of the public hospitals of the capital of Armenia. She has more than 7 years of medical practice as an ENT-specialist. Dr. Mkrtchyen received her Ph.D. in Medicine in 2015. Her research interest is focused on the study of the impact of ENT pathology and its treatment on patients’ life quality. Dr. Mkrtchyan is the author of 27 scientific articles and 1 monography.
For more details regarding the international conference "Pharmacology Congress 2020"Kindly contact :
Bommali S
Conference
Scientific Event Manager| Pharmacology Congress 2020 |
Longdom Conferences | LONGDOM
GROUP SA
Avenue Roger Vandendriessche, 18, 1150 Brussels, Belgium
Toll Free:
+3253280122 | Whatsapp: +32466903214
No comments:
Post a Comment